Clinical Challenges: Diagnosing Idiopathic Lung Fibrosis

(MedPage Today) -- Approval of two antifibrotic drugs for idiopathic pulmonary fibrosis (IPF)--pirfenidone (Esbriet) and nintedanib (Ofev)--represented a paradigm shift in the management of the progressive fibrotic disease and potentially...